A c c e p t e d m a n u s c r i p t 2 Abstract Objectives:
Introduction
Immature granulocytes (IG) are the precursors of neutrophils and include promyelocytes, myelocytes and metamyelocytes. IG are normally found in the bone marrow. With the exception of newborns, they are rarely observed in the peripheral blood of normal, healthy individuals. Therefore, the presence of IG in a peripheral blood sample is considered abnormal and indicates increased myeloid cell production, which can be the result of infection (especially of bacterial origin), as a response to severe inflammation, hematological myeloid diseases such as myelodysplastic or myeloproliferative syndroms or, finally, as a result of metastatic bone marrow infiltration by tumors. Accordingly, enumerating IG can be helpful, not only for detecting the aforementioned diseases, but also in monitoring treatment and progression of these diseases. 1 To date, the reference method for their enumeration is still the microscopic slide review. 2 Unfortunately, manual counts show a large inter-observer variation and poor reproducibility, especially when IG are present in low numbers in the peripheral blood. 3 The UniCel DxH 800 (Beckman Coulter, Brea, CA) is an automated analyzer capable of performing complete blood counts (CBC) and the leukocyte differential. 4 In addition, IG are classified using the expanded VCSn (Volume, Conductivity, Scatter with multiple angles) technologies on the DxH 800 and are called Early Granulocyte Cells (EGC%_DxH).
In our laboratory the differential workflow and slide review incorporates the DxH 800 connected to the HematoFlow (HF) (Beckman Coulter) immunodifferential flow cytometry process. 5 HematoFlow is an innovative technique that uses a cocktail of six monoclonal antibodies for immunophenotyping and production of an accurate A c c e p t e d m a n u s c r i p t software has been recently released and is implemented in our routine lab. 6 With this workflow, qualitative flags generated by the DxH 800 (i.e. Blast, Atypical lymphocyte and IG) trigger a HematoFlow immunodifferential with or without slides review. IG is the most frequent flag generated by Haematology Analyzers in our experience and this finding has been confirmed by other reports in the literature. 7 Therefore accurate, automatic and rapid quantification of IG could improve productivity, avoid unnecessary analyses and improve the time of reporting for clinicians to take appropriate action.
The primary objective of our study therefore was to evaluate the performances of the new EGC%_DxH count and compare this with the reference method used routinely in our laboratory. The secondary objective was to determine the reduction in the number of HF and/or slide reviews by the integration of the EGC%_DxH parameter into the algorithm of our routine workflow.
A c c e p t e d m a n u s c r i p t
Patient samples and study design
During a 10 day period (from January 28 th to February 8 th 2014), consecutive blood samples exhibiting an IG flag after CBC and leukocyte differential on DxH 800 were included in this study. CBC and leukocyte differential were performed on K2-EDTA anticoagulated blood samples from the clinical departments of University Hospital of Rennes, as recommended by manufacturer instructions. This non-interventional study did not require patient consent according to French law. In total 6,913 CBC samples were routinely processed during this evaluation period. As defined in our laboratory procedures, the IG flag does not allow automatic validation and generates a HF differential for verification. Briefly, after red blood cell lysis and immunostaining with CytoDiff Reagent on a FP1000 sample preparation system (Beckman Coulter), the HematoFlow leukocyte differential is performed as previously described with a FC500 flow cytometer (Beckman Coulter). 5 The CytoDiff CXP software version 2.0 was employed for automatic gating of the population of interest. 6 Accordingly to previous internal evaluation comparing Hematoflow and manual slide review, the threshold for IG obtained by Hematoflow (IG%_HF) is at 1.4% for a cut off at 1% on manual review (unpublished data). As such, in our routine procedure IG%_HF <1.4% is reported as zero on the CBC diff report. value of IG obtained by HematoFlow (IG%_HF) is considered as negative when the percentage is lower than 1.4% (unpublished data). As immature granulocytes are considered as pathological condition, in these cases, the IG% is reported as zero on the CBC-diff report. IG are defined as cells with high granularity on SS axis with lower expression of CD45 and CRTH2 than eosinophils on a biparametric dot-plot CD2-CRTH2/CD45. 5, 8 The IG phenotype is confirmed by a lower expression of CD16 and CD45 than mature neutrophils on SS/CD16 and SS/CD45 plots respectively which is used in the process of the validation. In our workflow, when IG are higher than 15% without previous results in the seven preceding days or if leukocytes are missidentified by HematoFlow, a systematic manual slide review is required to confirm the amount of IG.
Statistical analysis
For consecutive samples presenting with the IG flag on DxH 800, we recorded the automatic flags, absolute leucocyte count, EGC%_DxH, IG%_HF and a 200 cells manual differential count (IG%_manual) . Differences between these values were calculated. Demographic data (age and clinical departments) were also collected.
Discordant cases were defined either as a difference higher than 5% between the two techniques or by qualitative discrepancies (EGC%_DxH neg and IG%_HF pos ). For these cases, microscopic leucocyte differential were performed and each slide was were re-run 10 times. Coefficients of variation were calculated at 9.1%, 3.9% and 4.7% respectively. Then, we assessed the longitudinal reliability of ECG%_DxH by A c c e p t e d m a n u s c r i p t testing two samples with low or high level of IG% at the beginning and at the end of each series (every 8 hours in our institution). The coefficient of variation obtained with this method on two consecutive series, on the three DxH 800 with three different operators was of 7.63% and 5.70% for low (3% of IG) and high level (10% of IG) respectively (data not shown).
Threshold calculation on a training set
A first training set of 143 patients was evaluated in order to define the best threshold Major discrepancies defined as a difference higher than 5% between IG%_HF and EGC%_DxH were found in 16 samples. These are denoted and plotted in red in figure 2C and in Table 1 (Range from 5.6 to 77.9%). Further analysis of these 16 A c c e p t e d m a n u s c r i p t samples showed seven had a "Blast" flag requiring HF independently of IG% status.
Eight samples presented with others cytopenias (thrombocytopenia or neutropenia).
Eleven of these samples emanated from the Hematology-Oncology departments.
The biggest difference was found in a case of myeloblastic leukemia with 76% of myeloblasts identified both by HF and slide review. These myeloblasts were assessed as EGC% by the DxH (Figure 3A ).
We proposed a validation algorithm integrating the EGC%_DxH for patients presenting with "Imm Gran" flag ( Figure 2C ). Quantitative flags "Blasts" or "Atypical lymphocytes" require HF analysis whatever the differential count or EGC%_DxH. 6 This new version benefit of improvements notably useful in defining IG that were frequently misidentified with the version 1.0; for instance IG were sometime miscounted as eosinophils or CD16 dim polynuclear neutrophils incorrectly counted as IG, leading to high variability in IG count. 6 The version 1.0 was employed in recent papers and to our knowledge our work is the first one using the new version. 10 We showed that the EGC%_DxH correlated well with HF with a positive cut-off of 0.9% in an IG flagged population. In our ten day study of 6,913 samples we were able to demonstrate that incorporation of the EGC% from the DxH 800 into our routine slide review algorithm had a positive impact.
EGC%_DxH showed a very good overall correlation with our reference methods, HF and/or slide review (r=0.953). Linear regression and correlation obtained for EGC is comparable with the other classical leukocyte subpopulations which are present usually in smaller numbers -particularly monocytes and eosinophils which present A c c e p t e d m a n u s c r i p t with similar range of values in the peripheral blood. 5, 7, 8 The EGC%_DxH correlation as per our study showed similar performance to the quantification of immature granulocytes as seen with those generated by the Sysmex XE analyser platform. 11 Based on our study incorporation of the EGC% into our routine algorithm results in a reduction of 92/259 (36%) of samples that requires either HematoFlow differential and/or microscopical slide review.
In those samples where the EGC% was discrepant with HF we found some samples where eosinophils were misidentified as IG. This mis-classification can be identified by the operator, either by the difference in eosinophils count between DxH 800 and HematoFlow, or by the observation of the SS/CD45 and SS/CD16 plots (eosinophils are CD45high whereas IG are CD45low) ( Figure 3B ). Another possible reasons for IG mis-classification include exceptions when mature neutrophils can lose CD16 in pathologic conditions like severe sepsis 12 and paroxysmal nocturne hemoglobinuria 13 leading to false IG identification. These conditions can be easily suspected on HF histograms. Indeed, IG presents a gradual gain of CD16 during their maturation. Therefore, they exhibit a continuum of CD16 expression and as such a specific pattern on SS/CD16 histogram. In case of hematologic malignancy (PNH) or myelodysplastic syndromes, the pathologic cells exhibit a low but homogenous CD16 expression leading to a distinct cluster on SS/CD16 histogram ( Figure 3C ).
Otherwise, myeloblastic blasts can be identified as immature granulocytes by DxH but accurate flagging avoid automatic validation. HF histogram reviewing enable to suspect blasts with their lower CD45 expression and SS intensity, leading to a systematic slide review for each new diagnosis. Indeed, HF never substitutes a manually performed differential count for the initial diagnosis of hematologic malignancies. In all these malignant conditions where there is a potential risk of A c c e p t e d m a n u s c r i p t autovalidation of an incorrect EGC%, the incorporation in our algorithm of other criteria (flags, unknown cytopenia and samples from hematology departments) results in these samples being accurately identified and processed for HF and/or slide review (see Figure 2C) . As reported by et Allou et al, the workflow can also be improved by an automated flagging strategy on HematoFlow reviewing that enables an automatic validation of HF leukocyte differential 14 .
Therefore in conclusion DHX800 accurately quantifies the presence of immature granulocytes through the new EGC%_DxH parameter and can be safely integrated into the WBC differential workflow and the HematoFlow process. Thus we propose an improved validation algorithm, which integrates the EGC%_DxH from the DxH 800 Haematology Analyzer with our current HematoFlow strategy to further streamline and improve our slide review process. The EGC%_DxH parameter is automatically generated by the DxH 800 so therefore is available at no additional cost. It allows us to further reduce our slide review rate in IG flagged samples by 36% and also allows for improved turn-around time for reporting to clinicians in the various departments we service. Only minor discrepancies in low IG% may be missed however as our study showed these have little if any clinical relevance.
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